Added to YB: 2020-12-19
Pitch date: 2020-12-19
BYSI:US [bullish]
BeyondSpring Inc.
-87.63%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology.
Market Cap
$57.2M
Pitch Price
$11.64
Price Target
N/A
Dividend
N/A
EV/EBITDA
-6.19
P/E
-6.63
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
BEYONDSPRING INC COM BYSI:US
A summary for this pitch has not been created yet.
Read full article (0 min)